NEW YORK – Investment bank BTIG has initiated coverage of CareDx's stock with a Buy rating and a price target of $40.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.